Braemar Hotels & Resorts Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Braemar Hotels & Resorts Inc. on August 12, 2020. The filing addresses "Other Events" (Item 8.01) concerning amendments to the Company's equity distribution agreements.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial metric disclosed is the remaining capacity under the equity distribution agreement:
- Shares Available for Sale: Up to $50,000,000 aggregate offering price.
- Sales Agent Commission: Up to 2.0% of the gross sales price.
- Expense Reimbursement: The Sales Agent (UBS Securities LLC) agreed to reimburse the Company for up to $50,000 of expenses if $15,000,000 in shares are sold, and an additional $50,000 if $30,000,000 in shares are sold.
Material Changes
The filing reports two significant changes to the Company's capital raising arrangements:
- Termination of Morgan Stanley: Effective August 10, 2020, Morgan Stanley & Co. LLC terminated its role as a sales agent under the equity distribution agreement. No further sales will be made through this agent.
- Amendment with UBS Securities: On August 12, 2020, the Company, its Operating Partnership, and Ashford Hospitality Advisors LLC entered into an amendment to the equity distribution agreement with UBS Securities LLC. This amendment revises representations, warranties, and certain other provisions.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond the standard disclosure that the description of the agreement is qualified by reference to the full text of the exhibits. The Company retains the ability to sell shares via negotiated transactions, block trades, or "at-the-market" offerings on the New York Stock Exchange.
Investor Verification Checklist
- Verify the full text of the amended Equity Distribution Agreement (Exhibit 1.3) to understand the revised representations and warranties.
- Confirm the current status of the $50 million shelf registration (Form S-3 No. 333-223799) and any subsequent sales activity.
- Monitor future filings for actual sales of shares under the amended agreement with UBS Securities LLC.
- Review the Company's most recent 10-Q or 10-K for comprehensive financial metrics not included in this 8-K.